comprehensive -WSS

comprehensive

author：entertainment 2025-09-27 13:02:27 - browse：229

The FDA building -- First Opinion coverage from STAT — Adobe

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakier ground following a Food and Drug Administration advisory committee meeting Thursday.

Regulatory advisers voted 10-2 that the data on the company’s drug Lumakras, a treatment for lung cancer, could not be properly assessed. Lumakras targets a specific mutation to a protein called KRAS, which is one of the most common genetic mutations in cancer.

The vote comes as Amgen is hoping to convert a conditional approval for the drug to a full approval based on a 345-person study called CodeBreaK 200, in which Lumakras met the primary endpoint, delaying tumor growth approximately five weeks longer than the standard of care medication, docetaxel. The drug didn’t extend patients’ overall survival.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Boston's new lab space is opening empty

Wikipedia

WSS

Male and female sex labels in research insufficient, scientists say

Prescription digital therapeutics are key to pharma’s future

Hubble vs. James Webb telescope images: See the difference

Drug cartel violence flares in western Mexico after vigilante leader's killing

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Wikipedia

comprehensive

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

What affirmative action's end means to a medical student

Duchenne breakthrough therapy leaves behind pioneering families

Drug cartel violence flares in western Mexico after vigilante leader's killing

Bright Health sells Medicare Advantage business to Molina

How Robert F. Kennedy Jr. distorted vaccine science

Apple is now the first public company to be valued at $3 trillion

Skip the lead apron during X

Hollywood unions extend contract negotiations for actors

Readout Newsletter: CAR

hotspot

Male and female sex labels in research insufficient, scientists say

How to save health care price transparency rules

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Canadians with cystic fibrosis outlive Americans by a decade

Canadians with cystic fibrosis outlive Americans by a decade

EPA limits use of carcinogenic gas for sterilizing medical devices

focus

hotspot

Wikipedia

Wikipedia